October 20, 2020 -- Proteintech, a German-based producer of antibodies, proteins, and immunoassays, has acquired ChromoTek, a manufacturer of camelid single-domain antibodies (aka nanobodies).
ChromoTek produces the nanobodies with high-performance recombinant reagents. Combined with Proteintech, the companies will address growing opportunities in single-cell analysis, super-resolution imaging, and multiplex assays.
Proteintech has a large portfolio of self-manufactured antibodies covering two-thirds of the human proteome. The company also offers cytokines, growth factors, and other human-expressed proteins.
Financial details were not disclosed.
Copyright © 2020 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
